//
Amelie Schramm
Thomas W. P. Friedl
Fabienne Schochter
Volkmar Mueller
Bahriye Aktas
Klaus Pantel
Natalia Krawczyk
Wolfgang Janni
Brigitte Kathrin Rack
Marianna Alunni-Fabbroni
Peter A. Fasching
Florin-Andrei Taran
Andreas D. Hartkopf
Andreas Schneeweiss
II. Medical Clinic & Institute of Tumor Biology, Campus Forschung, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Universitatsklinikum Ulm, Ulm, Germany
Heidelberg University Hospital, Heidelberg, Germany
Department of Gynecology and Obstetrics University Ulm, Ulm, Germany
University of Ulm, Ulm, Germany
Comprehensive Cancer Center, Erlangen, Germany
University Hospital of Essen, Essen, Germany
I. Universitaetsfrauenklinik, Hebertshausen, GermanyDepartment of Gynecology and Obstetrics, Ludwig-Maximilians-University Munich, Munich, GermanyDivision of Gynecological Oncology, Dept. Obstetrics and Gynecology, Ulm University, Ulm, Germany
University Medical Center Hamburg Eppendorf, Hamburg, Germany
Department of Gynecology and Obstetrics University Ulm, Ulm, Germany
University Hospital, Duesseldorf, Germany
Department of Gynecology and Obstetrics Heinrich-Heine-University Dusseldorf, Duesseldorf, Germany
Universitatsklinikum Ulm, Ulm, Germany
Department of Gynecology and Obstetrics, University of Tuebingen, Tuebingen, Germany
Germany
N/A
Oncology (ONC)
Breast cancer
Circulating tumor cells
Human epidermal growth factor receptor 2
N/A
N/A
N/A
NA
N/A
N/A
N/A